Genome-Wide Meta-analysis Identifies Genetic Variants Associated With Glycemic Response to Sulfonylureas
出版年份 2021 全文链接
标题
Genome-Wide Meta-analysis Identifies Genetic Variants Associated With Glycemic Response to Sulfonylureas
作者
关键词
-
出版物
DIABETES CARE
Volume 44, Issue 12, Pages 2673-2682
出版商
American Diabetes Association
发表日期
2021-10-05
DOI
10.2337/dc21-1152
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Efficacy of Modern Diabetes Treatments DPP-4i, SGLT-2i, and GLP-1RA in White and Asian Patients With Diabetes: A Systematic Review and Meta-analysis of Randomized Controlled Trials
- (2020) Sushrima Gan et al. DIABETES CARE
- Notch1 Has an Important Role in β-Cell Mass Determination and Development of Diabetes
- (2020) Young Sil Eom et al. Diabetes & Metabolism Journal
- Dissecting the Contribution of OATP1B1 to Hepatic Uptake of Statins Using the OATP1B1 Selective Inhibitor Estropipate
- (2019) Yueping Zhang et al. MOLECULAR PHARMACEUTICS
- Discovery of biomarkers for glycaemic deterioration before and after the onset of type 2 diabetes: descriptive characteristics of the epidemiological studies within the IMI DIRECT Consortium
- (2019) Robert W. Koivula et al. DIABETOLOGIA
- The presence of two reduced function variants in CYP2C9 influences the acute response to glipizide
- (2019) L. Chen et al. DIABETIC MEDICINE
- A New Liver Expression Quantitative Trait Locus Map From 1,183 Individuals Provides Evidence for Novel Expression Quantitative Trait Loci of Drug Response, Metabolic, and Sex‐Biased Phenotypes
- (2019) Amy S. Etheridge et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Interaction of Sulfonylureas with Liver Uptake Transporters OATP1B1 and OATP1B3
- (2018) Yu Chen et al. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY
- TCF7L2Genetic Variation Augments Incretin Resistance and Influences Response to a Sulfonylurea and Metformin: The Study to Understand the Genetics of the Acute Response to Metformin and Glipizide in Humans (SUGAR-MGH)
- (2018) Shylaja Srinivasan et al. DIABETES CARE
- Time trends and geographical variation in prescribing of drugs for diabetes in England from 1998 to 2017
- (2018) Helen J. Curtis et al. DIABETES OBESITY & METABOLISM
- Longitudinal trends and predictors of statin use among patients with diabetes
- (2018) Meghan B. Brennan et al. JOURNAL OF DIABETES AND ITS COMPLICATIONS
- Sex and BMI Alter the Benefits and Risks of Sulfonylureas and Thiazolidinediones in Type 2 Diabetes: A Framework for Evaluating Stratification Using Routine Clinical and Individual Trial Data
- (2018) John M. Dennis et al. DIABETES CARE
- CYP2C9 and OATP1B1 genetic polymorphisms affect the metabolism and transport of glimepiride and gliclazide
- (2018) Fayou Yang et al. Scientific Reports
- SumHer better estimates the SNP heritability of complex traits from summary statistics
- (2018) Doug Speed et al. NATURE GENETICS
- Severe hypoglycemia in users of sulfonylurea antidiabetic agents and antihyperlipidemics
- (2016) CE Leonard et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Metabolomic and Genome-wide Association Studies Reveal Potential Endogenous Biomarkers for OATP1B1
- (2016) SW Yee et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Variation in the glucose transporter gene SLC2A2 is associated with glycemic response to metformin
- (2016) Kaixin Zhou et al. NATURE GENETICS
- Predictors of response in initial users of metformin and sulphonylurea derivatives: a systematic review
- (2015) D. P. Martono et al. DIABETIC MEDICINE
- The Study to Understand the Genetics of the Acute Response to Metformin and Glipizide in Humans (SUGAR-MGH): Design of a pharmacogenetic Resource for Type 2 Diabetes
- (2015) Geoffrey A. Walford et al. PLoS One
- Quality control and conduct of genome-wide association meta-analyses
- (2014) Thomas W Winkler et al. Nature Protocols
- Heritability of variation in glycaemic response to metformin: a genome-wide complex trait analysis
- (2014) Kaixin Zhou et al. Lancet Diabetes & Endocrinology
- OATP1B3 Is Expressed in Pancreatic -Islet Cells and Enhances the Insulinotropic Effect of the Sulfonylurea Derivative Glibenclamide
- (2013) H. E. Meyer zu Schwabedissen et al. DIABETES
- Estimating the effect of sulfonylurea on HbA1c in diabetes: a systematic review and meta-analysis
- (2013) J. A. Hirst et al. DIABETOLOGIA
- Negative Regulation of Notch Signaling by Xylose
- (2013) Tom V. Lee et al. PLoS Genetics
- Steroid hormones specifically modify the activity of organic anion transporting polypeptides
- (2012) Anna Koenen et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- CYP2C metabolism of oral antidiabetic drugs - impact on pharmacokinetics, drug interactions and pharmacogenetic aspects
- (2012) Andreas Holstein et al. Expert Opinion on Drug Metabolism & Toxicology
- Large-scale association analysis provides insights into the genetic architecture and pathophysiology of type 2 diabetes
- (2012) NATURE GENETICS
- LocusZoom: regional visualization of genome-wide association scan results
- (2010) R. J. Pruim et al. BIOINFORMATICS
- GWAMA: software for genome-wide association meta-analysis
- (2010) Reedik Mägi et al. BMC BIOINFORMATICS
- Influence of atorvastatin on the pharmacokinetics and pharmacodynamics of glyburide in normal and diabetic rats
- (2010) Prasad Neerati et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Common variants near ATM are associated with glycemic response to metformin in type 2 diabetes
- (2010) Kaixin Zhou et al. NATURE GENETICS
- Identification of the major human hepatic and placental enzymes responsible for the biotransformation of glyburide
- (2009) Olga L. Zharikova et al. BIOCHEMICAL PHARMACOLOGY
- Loss-of-Function CYP2C9 Variants Improve Therapeutic Response to Sulfonylureas in Type 2 Diabetes: A Go-DARTS Study
- (2009) K Zhou et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Pharmacogenetics and future strategies in treating hyperglycaemia in diabetes
- (2009) Ewan et al. Frontiers in Bioscience-Landmark
- A Flexible and Accurate Genotype Imputation Method for the Next Generation of Genome-Wide Association Studies
- (2009) Bryan N. Howie et al. PLoS Genetics
- Elucidating Rifampin's Inducing and Inhibiting Effects on Glyburide Pharmacokinetics and Blood Glucose in Healthy Volunteers: Unmasking the Differential Effects of Enzyme Induction and Transporter Inhibition for a Drug and Its Primary Metabolite
- (2008) HX Zheng et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started